Envista Holdings Corp (NVST) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock shows positive financial growth, favorable analyst sentiment, and a stable technical setup, making it a solid choice for a long-term portfolio.
The technical indicators suggest a bullish trend. The MACD histogram is positive at 0.217, the RSI is neutral at 60.245, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading above the key pivot level of 26.326, with resistance levels at 27.384 and 28.038, indicating potential upward movement.

Strong Q4 2025 financial performance with revenue up 14.96% YoY and net income up 2641.67% YoY.
Analysts have set an average price target of $28.50, indicating potential upside.
Multiple analysts have upgraded the stock to Outperform, citing strong growth and execution.
Recent overweight rating and positive news sentiment may attract institutional interest.
Citi's neutral rating and cautious view on the dental sector due to macroeconomic pressures.
Gross margin dropped by 3.74% YoY, which may indicate cost pressures.
Envista Holdings demonstrated strong financial performance in Q4 2025. Revenue increased by 14.96% YoY to $750.6M, net income surged by 2641.67% YoY to $32.9M, and EPS grew by 1900% YoY to $0.2. However, gross margin declined by 3.74% YoY to 55.04%.
Analysts are generally optimistic about NVST, with several upgrades to Outperform and price target increases. The average price target is $28.50, suggesting potential upside from the current price of $26.94. However, Citi remains neutral on the stock due to macroeconomic concerns in the dental sector.